The S&P 500 and Nasdaq have both felt pressure as shares of major tech companies came under pressure Monday. Investors ...

Additionally, investors should keep an eye on any recent revisions to analyst forecasts for CVS Health. These revisions typically reflect the latest short-term business trends, which can change ...

A popular brand of eye drops is being recalled nationwide due ... EYE PRODUCTS SOLD AT WALMART, CVS COULD POSE INFECTION RISK If an infection occurs, the FDA said it may be vision-threatening ...

CVS Health (CVS) closed at $51.96 in the latest trading session, marking a -0.35% move from the prior day. This move lagged the S&P 500's daily loss of 0.21%. Elsewhere, the Dow lost 0.16%, while the ...

Broader health insurance and PBM sector stocks including Centene, CVS, Elevance Health and Humana decline as investors react to market. What To Know: UnitedHealth, the largest health insurer in ...

The product may be used to treat a condition that the American Academy of Ophthalmology says affects around 20 million ...

It is unclear what type of fungus the eye drops are contaminated with. One lot of eye drops is being voluntarily recalled due to potential fungal contamination, the U.S. Food and Drug ...

Select eye drops under the Systane brand were voluntarily recalled for concerns of fungal contamination, which could cause eye infection and threaten users' vision, according to a recall ...